Literature DB >> 11431387

Breast cancer patients can stop tamoxifen after 5 years.

S Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11431387      PMCID： PMC1071453          DOI： 10.1136/ewjm.175.1.13

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  2 in total

1.  Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.

Authors:  B Fisher; J Dignam; J Bryant; N Wolmark
Journal:  J Natl Cancer Inst       Date:  2001-05-02       Impact factor: 13.506

2.  Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.

Authors:  B Fisher; A Brown; N Wolmark; C Redmond; D L Wickerham; J Wittliff; N Dimitrov; S Legault-Poisson; H Schipper; D Prager
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.